SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-033471
Filing Date
2018-05-15
Accepted
2018-05-15 16:32:23
Documents
85
Period of Report
2018-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a18-8632_110q.htm 10-Q 826605
2 EX-10.1 a18-8632_1ex10d1.htm EX-10.1 665661
3 EX-10.2 a18-8632_1ex10d2.htm EX-10.2 288883
4 EX-31.1 a18-8632_1ex31d1.htm EX-31.1 10468
5 EX-31.2 a18-8632_1ex31d2.htm EX-31.2 10407
6 EX-32.1 a18-8632_1ex32d1.htm EX-32.1 5698
7 EX-32.2 a18-8632_1ex32d2.htm EX-32.2 6212
14 GRAPHIC g86321fti001.jpg GRAPHIC 30297
15 GRAPHIC g86321km17i001.gif GRAPHIC 40774
16 GRAPHIC g86321km11i001.gif GRAPHIC 4510
  Complete submission text file 0001104659-18-033471.txt   6357020

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT ontx-20180331.xml EX-101.INS 1039810
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ontx-20180331.xsd EX-101.SCH 68525
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ontx-20180331_cal.xml EX-101.CAL 36372
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ontx-20180331_def.xml EX-101.DEF 244299
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ontx-20180331_lab.xml EX-101.LAB 490343
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ontx-20180331_pre.xml EX-101.PRE 414026
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 18837074
SIC: 2834 Pharmaceutical Preparations